This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ty, E. B. Articles by Rothner, A. D. Search for Related Content PubMed PubMed Citation Articles by Ty, E. B. Articles by Rothner, A. D. Social Bookmarking                         What's this?

Topical Review : Neuroleptic Malignant Syndrome in Children and Adolescents

Department of Neurology, Section of Pediatric Neurology, Cleveland Clinic Foundation, Cleveland, OH

A. David Rothner, MD

Department of Neurology, Section of Pediatric Neurology, Cleveland Clinic Foundation, Cleveland, OH

Neuroleptic malignant syndrome is a rare but potentially fatal complication of treatment with antipsychotic medications. Prior to 1994, there was no accepted set of diagnostic criteria. This article presents four adolescents admitted at Cleveland Clinic Foundation from 1985 to 1998, illustrating the broad spectrum of neuroleptic malignant syndrome. A review of the pediatric literature is discussed as to the current risk factors, pathogenesis, management, and outcome. Early recognition and supportive and specific treatment of neuroleptic malignant syndrome reduced the morbidity and mortality. (J Child Neurol 2001;16:157-163).

Journal of Child Neurology, Vol. 16, No. 3, 157-163 (2001)
DOI: 10.1177/088307380101600301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?